COMMUNIQUÉS West-GlobeNewswire

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
21/02/2018
BRIDGEWATER, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced the granting of [...]
Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine
21/02/2018
– Marked and Durable Responses Across TRK Fusion Cancers – – 75 Percent Overall Response Rate by Central Assessment; 80 Percent Overall Response Rate by Investigator Assessment – – 86 Percent of Responding Patients [...]
Integra LifeSciences to Present at Healthcare Conferences in March 2018
21/02/2018
PLAINSBORO, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, will present at the following healthcare conferences in March: [...]
SeaSpine to Report Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018
21/02/2018
CARLSBAD, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE ), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock
21/02/2018
CRANBURY, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced the closing of its previously announced offering of common stock. The Company issued a total of 19,354,839 shares in [...]
ContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until March 9, 2018
21/02/2018
3 of 4 Proposals pass with stockholder approval Annual Meeting adjourned solely with respect to Proposal 4 - Approval of Reverse Stock Split EDISON, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc [...]
Globus Medical Reports Full Year and Fourth Quarter 2017 Results
21/02/2018
AUDUBON, Pa., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, [...]
LeMaitre Q4 2017 Record Sales $26.2mm (+12%), Record Op. Income $6.3mm (+62%)
21/02/2018
BURLINGTON, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ), a provider of vascular devices, implants and services, today reported Q4 2017 results, provided guidance, and announced a 27 [...]
Atara Biotherapeutics Announces Chief Financial Officer Intention to Retire in April 2018
21/02/2018
Launches Search for Chief Financial Officer SOUTH SAN FRANCISCO, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing [...]
TRACON to Report Fourth Quarter and Full Year 2017 Company Highlights and Financial Results on February 28, 2018
21/02/2018
SAN DIEGO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
GenMark Diagnostics to Present at Upcoming Investor Conferences
21/02/2018
CARLSBAD, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK ) today announced that the Company plans to participate in two upcoming investor conferences. March 1, 2018, GenMark’s [...]
G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights
21/02/2018
Topline data expected in March 2018 from first of three ongoing Phase 2 trials evaluating the myelopreservation benefits of trilaciclib Management to host webcast and conference call today at 4:30 p.m. EST RESEARCH [...]
GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006
21/02/2018
-Study did not meet its primary endpoint- -Company remains committed to continued development of GWP42006 for autism spectrum disorders and will continue to explore the product’s potential within the field of epilepsy- [...]
Achaogen Announces New Employment Inducement Grants
21/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]
Cerner Implements Surescripts Prescription Price Transparency Functionality Within the EHR
21/02/2018
KANSAS CITY, Mo., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Cerner, a global leader in health care technology, is collaborating with Surescripts to integrate their Real-Time Prescription Benefit functionality into the Cerner [...]
PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2017 Results and Provides Q1 and FY 2018 Guidance
21/02/2018
Net new business of $647.3 million in the fourth quarter; Net book-to-bill of 1.30 $568.8 million of service revenue in the fourth quarter; 37.5% actual growth and 20.2% organic growth at actual foreign exchange rates [...]
Taconic Biosciences Announces the Formation of Scientific Advisory Board
21/02/2018
RENSSELAER, N.Y., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced the formation of its Scientific Advisory Board (SAB) [...]
Nextech’s 2018 EDGE User Conference Brings Together Medical Specialty Professionals for Expansive Knowledge Exchange
21/02/2018
TAMPA, Fla., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, will host its fourth annual user conference, EDGE, February 22- [...]
Mission Pharmacal enters into agreement with MainPointe Pharmaceuticals to purchase and license Mission’s consumer products
21/02/2018
SAN ANTONIO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Mission Pharmacal Company (“Mission”) announced today that it has recently divested several consumer products to MainPointe Pharmaceuticals, LLC (“MainPointe”). In addition [...]

Pages